Quick Answer
Inspire Medical Systems, Inc. reported Total Revenue of $911.98 million for fiscal year 2025.
Inspire Medical Systems, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $911.98M +13.6% |
$802.80M +28.5% |
$624.80M +53.2% |
$407.86M +74.7% |
$233.39M +102.3% |
$115.38M +40.6% |
| Revenue (ASC 606) | $911.98M +13.6% |
$802.80M +28.5% |
$624.80M +53.2% |
$407.86M +74.7% |
$233.39M +102.3% |
$115.38M +40.6% |
| Net Income | $145.42M +171.8% |
$53.51M +353.0% |
-$21.15M +52.9% |
-$44.88M -6.8% |
-$42.04M +26.5% |
-$57.20M -72.1% |
| Diluted EPS | $4.89 +179.4% |
$1.75 +343.1% |
-$0.72 +55.0% |
-$1.60 -3.9% |
-$1.54 +29.7% |
-$2.19 -56.4% |
| Total Assets | $907.32M +12.2% |
$808.38M +19.4% |
$676.81M +19.8% |
$564.88M +91.4% |
$295.08M +4.9% |
$281.19M +55.1% |
| Cash and Equivalents | $104.81M -30.2% |
$150.15M -19.1% |
$185.54M -58.0% |
$441.59M +105.9% |
$214.47M +12.6% |
$190.52M +733.4% |
| Stockholders Equity | $781.16M +13.3% |
$689.70M +20.5% |
$572.51M +15.4% |
$496.01M +116.6% |
$229.05M -0.3% |
$229.75M +64.3% |
| R&D Expense | $103.17M -9.6% |
$114.13M -2.1% |
$116.54M +69.8% |
$68.64M +83.8% |
$37.35M +43.1% |
$26.09M +103.2% |
| Operating Income | $50.95M +41.2% |
$36.08M +189.6% |
-$40.27M +15.4% |
-$47.59M -19.4% |
-$39.85M +29.1% |
-$56.21M -61.1% |
| Gross Profit | $778.76M +14.6% |
$679.82M +28.7% |
$528.22M +54.6% |
$341.74M +70.8% |
$200.12M +104.7% |
$97.76M +42.9% |
| Shares Outstanding | 28.58M -3.9% |
29.74M +0.6% |
29.56M +1.9% |
29.01M +5.8% |
27.42M +1.3% |
27.07M +12.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $224.50M | +10.5% | +3.4% |
| Revenue (ASC 606) | September 30, 2025 | $224.50M | +10.5% | +3.4% |
| Net Income | September 30, 2025 | $9.93M | -46.3% | +376.5% |
| Diluted EPS | September 30, 2025 | $0.34 | -43.3% | +383.3% |
| Total Assets | September 30, 2025 | $807.72M | +1.4% | +0.7% |
| Cash and Equivalents | September 30, 2025 | $112.84M | -23.5% | +5.5% |
| Stockholders Equity | September 30, 2025 | $666.46M | -4.3% | -1.7% |
| R&D Expense | September 30, 2025 | $24.21M | -7.2% | -7.6% |
| Operating Income | September 30, 2025 | $9.64M | -32.6% | +390.8% |
| Gross Profit | September 30, 2025 | $192.73M | +12.8% | +5.7% |
| Shares Outstanding | September 30, 2025 | 29.05M | -3.0% | -1.7% |
- Inspire Medical Systems, Inc. reported Total Revenue of $911.98 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +13.6% in Total Revenue compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Revenue (ASC 606) of $911.98 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +13.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Net Income of $145.42 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +171.8% in Net Income compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Diluted EPS of $4.89 per share for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +179.4% in Diluted EPS compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Total Assets of $907.32 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +12.2% in Total Assets compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Cash and Equivalents of $104.81 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed a decrease of -30.2% in Cash and Equivalents compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Stockholders Equity of $781.16 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +13.3% in Stockholders Equity compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported R&D Expense of $103.17 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed a decrease of -9.6% in R&D Expense compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Operating Income of $50.95 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +41.2% in Operating Income compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Gross Profit of $778.76 million for fiscal year 2025.
- Inspire Medical Systems, Inc. showed an increase of +14.6% in Gross Profit compared to the prior fiscal year.
- Inspire Medical Systems, Inc. reported Shares Outstanding of 28.58 million shares for fiscal year 2025.
- Inspire Medical Systems, Inc. showed a decrease of -3.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: